Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

6 tricks that pharmaceutical marketers use

Martha Rosenberg
Meds
May 30, 2017
Share
Tweet
Share

Long before the Internet and direct-to-consumer advertising, the medical profession tried to reassure people about their health concerns. Remember “take two aspirins and call me in the morning?”

Flash forward to today’s online “symptom checkers.” They are quizzes to see if someone has a certain disease and exhortations to see their doctor even if they feel fine. Once drug makers discovered that health fears and even hypochondria sell drugs, there seems to be no end to the new diseases, symptoms and risks people need to worry about.

In fact, since drug ads began on TV, Americans take so many drugs it inspires satirical T-shirts like the one that says:

“I take aspirin for the headache caused by the Zyrtec I take for the hay fever I got from Relenza for the uneasy stomach from the Ritalin I take for the short attention span caused by the Scopoderm I take for the motion sickness I got from the Lomotil I take for the diarrhea caused by the Xenical for the uncontrolled weight gain from the Paxil I take for the anxiety from Zocor I take for my high cholesterol because exercise, a good diet and regular chiropractic care are just too much trouble.”

Here are some of the ways ads use fear to keep the public buying drugs.

1. Fear of aging and losing sex appeal. Hormone replacement therapy which millions of women took until 15 years ago was officially marketed to stop hot flashes and keep bones strong. But unofficially, it was marketed as a way of staying young and sexy as marketed by glamorous models and actresses. Early HRT ads told women they had “outlived their ovaries” and not kept up with their husbands who wanted younger looking women. More recently, “low-T” drug advertising tells men the same thing. According to drug marketers, people don’t have lower hormone levels because they age, they age because they have lower hormone levels.

2. Fear of everyday symptoms. Once upon a time, people with heartburn took Tums, Alka-Seltzer or Maalox and vowed not to eat so much. They did not worry they had gastroesophageal reflux disease (GERD), were on their way to cancer of the esophagus and take proton pump inhibitors like Nexium for the rest of their lives. Similarly, having the blues over problems with marriage, family, jobs or finances was not termed “depression.” Nor were energetic little boys immediately said to be suffering from ADHD.

3. Fear of new diseases. From the aggressive marketing of “shift-work sleep disorder” and “non-24-hour sleep-wake disorder” to exocrine pancreatic insufficiency (EPI) drug makers raise fears about obscure diseases that are so rare they would never be advertised unless “demand” was being created. Humira-maker AbbVie, in addition to raising “awareness” about EPI, warns people their back pain could be ankylosing spondylitis.

4. Fear that your child is not normal. ADHD is not the only way drug marketers have medicalized and monetized childhood. Temper tantrums are now called “disruptive mood dysregulation disorder.” Thanks to “pediatric psychopharmacology” children are increasingly diagnosed with oppositional defiant disorders, mixed manias, social phobias, bipolar disorders, conduct disorders, depression and “spectrum” disorders. Children are compliant patients who have no choice but to do what they parents, teachers and doctors tell them. Worse, they stay on the drugs for decades with no way of knowing if they need they them now — or ever needed them.

5. Fear that your drug isn’t working. Adding a second drug to a first one maximizes revenue. But is it ethical? If a first drug is not working why take it? Maybe you never needed it. In past years, campaigns told people to add Abilify or Seroquel to their antidepressant to make it work better. Industry-funded doctors simultaneously reclassified depression as a life-long and even progressive condition — though it was considered neither before expensive drugs to treat it emerged. Having a progressive condition that is not being treated increases the “fear” sell of course.

6. Fear of silent diseases. According to drug ads, just because you have no symptoms doesn’t mean you aren’t suffering from silent conditions. You might be “at risk “ of bone loss said ads for anti-osteoporosis drugs like Fosamax, Boniva and Prolia (once the money in hormone replacement ran out). No pill in the history of the world has been as successful as the statin Lipitor with its “Know Your Numbers” TV ad campaign. Yet dietary cholesterol as a strong risk factor in heart disease has recently been questioned. And the ads don’t mention diet and exercise.

Such fear tactics to sell drugs are everywhere and why it is said that the healthiest people are those who do not watch TV drug ads.

Martha Rosenberg is a health reporter and the author of Born With a Junk Food Deficiency.  

ADVERTISEMENT

Image credit: Shutterstock.com 

Prev

Why we shouldn't pigeonhole patients into groups

May 30, 2017 Kevin 2
…
Next

When the medical student isn't the most important person

May 30, 2017 Kevin 1
…

Tagged as: Medications

Post navigation

< Previous Post
Why we shouldn't pigeonhole patients into groups
Next Post >
When the medical student isn't the most important person

ADVERTISEMENT

More by Martha Rosenberg

  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • How drug companies profit by inventing diseases

    Martha Rosenberg
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg

Related Posts

  • It’s time for presidential candidates to debate the safety of pharmaceutical products

    Steven Reznick, MD
  • How one woman prevented a pharmaceutical disaster

    James Essinger and Sandra Koutzenko
  • Second-tier, off-label treatments for anxiety

    Wallace B. Mendelson, MD
  • Sleep and the medical profession have an uneasy relationship

    Yoo Jung Kim, MD
  • Medical school and the science of sleep

    Sarah Murad
  • Don’t use stimulants to cram for exams. It ruins sleep and doesn’t help test scores.

    Sara C. Mednick, PhD

More in Meds

  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • Most Popular

  • Past Week

    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
    • The difference between a doctor and a physician

      Mick Connors, MD | Physician
    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
    • The debate on English tests for immigrant nurses

      Lynne Moronski, PhD, MPA, RN | Conditions
  • Past 6 Months

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • The hypocrisy of insurance referral mandates

      Ryan Nadelson, MD | Physician
  • Recent Posts

    • My persistent adverse reaction to an SSRI

      Scott McLean | Meds
    • Why carrier screening results are complex

      Oluyemisi Famuyiwa, MD | Conditions
    • The crisis in modern autism diagnosis

      Ronald L. Lindsay, MD | Conditions
    • A poem about being seen by your doctor

      Michele Luckenbaugh | Conditions
    • A doctor’s cure for imposter syndrome

      Noah V. Fiala, DO | Physician
    • Why humanity matters in medicine [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 4 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
    • The difference between a doctor and a physician

      Mick Connors, MD | Physician
    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
    • The debate on English tests for immigrant nurses

      Lynne Moronski, PhD, MPA, RN | Conditions
  • Past 6 Months

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • The hypocrisy of insurance referral mandates

      Ryan Nadelson, MD | Physician
  • Recent Posts

    • My persistent adverse reaction to an SSRI

      Scott McLean | Meds
    • Why carrier screening results are complex

      Oluyemisi Famuyiwa, MD | Conditions
    • The crisis in modern autism diagnosis

      Ronald L. Lindsay, MD | Conditions
    • A poem about being seen by your doctor

      Michele Luckenbaugh | Conditions
    • A doctor’s cure for imposter syndrome

      Noah V. Fiala, DO | Physician
    • Why humanity matters in medicine [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

6 tricks that pharmaceutical marketers use
4 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...